Development Of Pre-Clinical Murine Models For Fibrolamellar Hepatocellular Carcinoma
RNA-seq (gene expression) · mouse · 19 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Mus musculus (mouse)
- Samples
- 19 samples: 5 × Control treated subcutaneous FL8 allograft tumor # vs 5 × Palbociclib treated subcutaneous FL8 allograft tumor # vs 5 × embryonic liver , control-S vs 4 × embryonic liver , DNAJ1B-PKA_Overexpression-SGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE249325_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1048524 and SRA study SRP475742. Searching any of these in the dataset finder brings you back here.
Supports a case/control comparison: 9 samples read as cases, 5 as controls.
How we read this: 4 replicated groups read from 19 sample titles; they account for 19 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM7934019 Control treated subcutaneous FL8 allograft tumor #1 Control treated subcuta…
- GSM7934020 Control treated subcutaneous FL8 allograft tumor #2 Control treated subcuta…
- GSM7934021 Control treated subcutaneous FL8 allograft tumor #3 Control treated subcuta…
- GSM7934022 Control treated subcutaneous FL8 allograft tumor #4 Control treated subcuta…
- GSM7934023 Control treated subcutaneous FL8 allograft tumor #5 Control treated subcuta…
- GSM7934024 Palbociclib treated subcutaneous FL8 allograft tumor #1 Palbociclib treated sub…
- GSM7934025 Palbociclib treated subcutaneous FL8 allograft tumor #2 Palbociclib treated sub…
- GSM7934026 Palbociclib treated subcutaneous FL8 allograft tumor #3 Palbociclib treated sub…
- GSM7934027 Palbociclib treated subcutaneous FL8 allograft tumor #4 Palbociclib treated sub…
- GSM7934028 Palbociclib treated subcutaneous FL8 allograft tumor #5 Palbociclib treated sub…
- GSM8303922 embryonic liver , control-S1 embryonic liver , contr…
- GSM8303923 embryonic liver , control-S2 embryonic liver , contr…
- GSM8303924 embryonic liver , control-S3 embryonic liver , contr…
- GSM8303925 embryonic liver , control-S4 embryonic liver , contr…
- GSM8303926 embryonic liver , control-S5 embryonic liver , contr…
- GSM8303927 embryonic liver , DNAJ1B-PKA_Overexpression-S6 embryonic liver , DNAJ1…
- GSM8303928 embryonic liver , DNAJ1B-PKA_Overexpression-S7 embryonic liver , DNAJ1…
- GSM8303929 embryonic liver , DNAJ1B-PKA_Overexpression-S8 embryonic liver , DNAJ1…
- GSM8303930 embryonic liver , DNAJ1B-PKA_Overexpression-S9 embryonic liver , DNAJ1…
- GSE301912 Delineation of the oncogenic potential of AKT downstream targets in murine and human hepatocellular carcinoma 20 samples shares hepatocellular
- GSE233074 Analysis of MLK3-dependent gene expression in carcinogen-induced murine hepatocellular carcinoma 10 samples shares hepatocellular
- GSE301030 Inhibiting B-cell-mediated Immunosuppression to Enhance the Immunotherapy Efficacy in Hepatocellular Carcinoma 54 samples shares hepatocellular
- GSE243017 The Loss of an orphan Nuclear Receptor augments Wnt/β-Catenin signaling via epigenetic dysregulation that promotes Sp1 and Myc interactions in Hepatocellular Carcinoma Development [RNA-seq] 6 samples shares hepatocellular
- GSE302836 Loss of Hepatocyte PI3Ka Protects Mice from Hepatocellular Carcinoma in association with altered lipid metabolism gene expression 42 samples shares hepatocellular
- GSE303515 Sequential adaptive changes in a c-Myc-driven model of hepatocellular carcinoma 34 samples shares hepatocellular
- GSE230972 Loss of cisPTase function in the liver promotes a highly penetrant form of fatty liver disease that rapidly transitions to hepatocellular carcinoma 27 samples shares hepatocellular
- GSE308568 The origin of hepatocellular carcinoma is regulated by metabolic zonation [RNA-seq] 26 samples shares hepatocellular
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.